Renal Cancer

Videos

Toni Choueiri, MD, Shares Positive Findings in Brain Metastases from RCC

02/16/2021

Dr Choueiri talks about results from a retrospective analysis of patients with metastatic RCC and brain metastases.

Dr Choueiri talks about results...

02/16/2021

Oncology

Videos

Dr Choueiri Highlights Nivolumab Plus Cabozantinib vs Sunitinib for Advanced RCC

02/16/2021

Toni Choueiri, MD, shares results from a new analysis of the phase 3 Checkmate 9ER trial of cabozantinib plus nivolumab for the first-line treatment of advanced RCC.

Toni Choueiri, MD, shares...

02/16/2021

Oncology

Videos

Scott Tykodi, MD, PhD, Discusses Gene Expression Analysis and Mutational Profiling in KEYNOTE-427 Trial for RCC

07/10/2020

Dr Tykodi shares data analyses of cohort A from the KEYNOTE-427 trial on first-line pembrolizumab for clear cell renal cell carcinoma, presented in two abstracts at the virtual 2020 ASCO Annual Meeting.

Dr Tykodi shares data analyses...

07/10/2020

Oncology

Videos

Pembrolizumab Yields Impressive Ongoing Responses in Treatment-Naive RCC

06/03/2020

David McDermott, MD, discusses the encouraging follow-up findings of the KEYNOTE-427 clinical trial.

David McDermott, MD, discusses...

06/03/2020

Oncology

Podcasts

“Spectacular” Trial Results Establish New Standard of Care for Advanced Kidney Cancer

02/21/2019

Dr Rini discusses the pivotal results of the KEYNOTE-426 trial, which compared the use of axitinib plus pembrolizumab with sunitinib in treatment-naïve patients with advanced kidney cancer.

Dr Rini discusses the pivotal...

02/21/2019

Oncology

Podcasts

Tivozanib Shows Promise Over Sorafenib in Patients With Advanced, Treatment-Refractory RCC

02/16/2019

Dr Rini talks about the findings of the TIVO-3 clinical trial, which compared the use of tivozanib with sorafenib in patients with advanced, treatment-refractory RCC.

Dr Rini talks about the findings...

02/16/2019

Oncology

Podcasts

New Advances in Research Pave the Way for the Treatment of Nonclear Cell RCC

02/14/2019

David F. McDermott, MD, talks about the recent advances in the treatment landscape for patients with nonclear cell renal cell carcinoma.

David F. McDermott, MD, talks...

02/14/2019

Oncology

News

Immunotherapy Trumps TKI in Clear Cell RCC With Altered DDR Genes

02/14/2019

Patients with metastatic clear cell RCC and a loss of function in DNA damage repair (DDR) genes had better survival outcomes when treated with immunotherapy versus TKI therapy, according to study results presented at the 2019 ASCO GI Cancers...

Patients with metastatic clear...

02/14/2019

Oncology